Additional Information
Market: TSX
Sector: Medical
EPIC: PTI
Latest Price: 1.33  (0,00%)
52-week High: 2.74
52-week Low: 1.12
Market Cap: 171.79M
1 year chart
1 day chart
Patheon Inc
www.patheon.com

Patheon is a leading provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon's technologies and services range from pre-clinical development to manufacturing a full array of dosage forms.

Patheon signs commercialisation deal for OROS-based release products

27th Apr 2009, 2:40 pm

Patheon Inc (TSX: PTI), a provider of drug development and manufacturing services to the international pharmaceutical industry, said it has signed agreements to commercialize two OROS technology controlled release products from their Cincinnati facility.

The first product will launch in late 2009 and the second is planned to launch in the third quarter of 2010. Further details were not disclosed.

OROS is a specialized drug delivery technology used to achieve the controlled release of active drug substances. When a patient swallows an OROS tablet, water is drawn into a specially formulated portion of the tablet which swells, exerting pressure on the tablet drug layer. This gentle pressure forces the active drug out through laser-drilled holes in the tablet, allowing for a gradual release of the active drug substance.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.